We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.56%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$31.3B
AUM Growth
+$1.67B
Cap. Flow
+$1.83B
Cap. Flow %
5.84%
Top 10 Hldgs %
37.77%
Holding
1,441
New
112
Increased
695
Reduced
355
Closed
81

Top Buys

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$698M
2
NFLX icon
Netflix
NFLX
+$243M
3
VTR icon
Ventas
VTR
+$232M
4
META icon
Meta Platforms (Facebook)
META
+$184M
5
AMZN icon
Amazon
AMZN
+$153M

Sector Composition

Rank Sector Weight
1 Technology 30.75%
2 Real Estate 25.79%
3 Communication Services 11.7%
4 Consumer Discretionary 7.26%
5 Financials 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWZ icon
1151
iShares MSCI Brazil ETF
EWZ
$9.01B
$18K ﹤0.01%
580
-400
-41% -$12.7K
USHY icon
1152
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
$18K ﹤0.01%
475
+161
+51% +$6.03K
KYMR icon
1153
Kymera Therapeutics
KYMR
$8.69B
$17K ﹤0.01%
215
PTCT icon
1154
PTC Therapeutics
PTCT
$6.2B
$17K ﹤0.01%
230
-20
-8% -$1.45K
PTGX icon
1155
Protagonist Therapeutics
PTGX
$8.72B
$17K ﹤0.01%
190
CGC
1156
PUT
Canopy Growth
CGC
$367M
$16K ﹤0.01%
+13,900
New +$17.9K
VGIT icon
1157
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
$16K ﹤0.01%
275
-126
-31% -$7.58K
CGC
1158
Canopy Growth
CGC
$367M
$15K ﹤0.01%
+13,900
New +$17.9K
COGT icon
1159
Cogent Biosciences
COGT
$6.71B
$15K ﹤0.01%
416
ACAD icon
1160
Acadia Pharmaceuticals
ACAD
$4.46B
$14K ﹤0.01%
530
APGE icon
1161
Apogee Therapeutics
APGE
$10.1B
$13K ﹤0.01%
166
CRNX icon
1162
Crinetics Pharmaceuticals
CRNX
$8.88B
$13K ﹤0.01%
282
-22
-7% -$979
FOLD
1163
DELISTED
Amicus Therapeutics
FOLD
$13K ﹤0.01%
916
-70
-7% -$688
GPCR icon
1164
Structure Therapeutics
GPCR
$3.38B
$13K ﹤0.01%
186
-40
-18% -$1.63K
IMVT icon
1165
Immunovant
IMVT
$7.8B
$13K ﹤0.01%
501
-80
-14% -$1.78K
SRRK icon
1166
Scholar Rock
SRRK
$5.91B
$13K ﹤0.01%
296
ADMA icon
1167
ADMA Biologics
ADMA
$2.03B
$12K ﹤0.01%
670
-80
-11% -$1.35K
AMRX icon
1168
Amneal Pharmaceuticals
AMRX
$6.07B
$12K ﹤0.01%
933
-90
-9% -$1.03K
MIRM icon
1169
Mirum Pharmaceuticals
MIRM
$6.63B
$12K ﹤0.01%
158
NAMS icon
1170
NewAmsterdam Pharma
NAMS
$3.24B
$12K ﹤0.01%
335
-40
-11% -$1.46K
ACLX
1171
DELISTED
Arcellx
ACLX
$11K ﹤0.01%
174
LGND icon
1172
Ligand Pharmaceuticals
LGND
$5.83B
$11K ﹤0.01%
58
-5
-8% -$961
ONDS icon
1173
PUT
Ondas Inc
ONDS
$4.06B
$11K ﹤0.01%
+1,100
New +$8.84K
TARS icon
1174
Tarsus Pharmaceuticals
TARS
$2.54B
$11K ﹤0.01%
137
TERN
1175
DELISTED
Terns Pharmaceuticals
TERN
$11K ﹤0.01%
260
+109
+72% +$2.52K

Similar funds

Daiwa Securities Group's Q4 2025 Portfolio in Review

As of Q4 2025, Daiwa Securities Group held 1,441 positions worth $31.3B, up 5.6% from $29.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group deployed $1.83B of net new capital in Q4 2025, opening 112 new positions and adding to 695 existing holdings. Its largest new stake was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Real Estate and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $542M trimmed.

  • Daiwa Securities Group's largest Q4 2025 buy was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.
  • Daiwa Securities Group added most to Palantir in Q4 2025, an estimated $698M increase.
  • Daiwa Securities Group's biggest Q4 2025 reduction was ServiceNow, cutting an estimated $542M.
  • Daiwa Securities Group fully exited Eagle Materials in Q4 2025, selling an estimated $12.8M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $31.3B portfolio in Q4 2025.
  • Daiwa Securities Group opened 112 new positions and closed 81 in Q4 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $31.3B.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.